Nefazodone Level
Serzone
Test Codes
NMS 3145SP, Order as a Miscellaneous Send Out.
Department
Send Outs
Specimen Collection Criteria
Collect (preferred specimen): One plain Red-top tube.
Also acceptable: One Lavender-top EDTA tube or 5.0 mL random urine in a sterile collection container. (Minimum: 0.7 mL)
Do not use Serum Separator Tubes.
Time of Collection: Trough, just prior to the next dose.
Physician Office/Draw Specimen Preparation
Centrifuge to separate serum or plasma from cells. Transfer serum or plasma to a plastic transport tube and refrigerate (2-8°C or 36-46°F). Maintain urine specimen refrigerated.
Preparation for Courier Transport
Transport: 1.0 mL serum, plasma, or urine, refrigerated (2-8°C or 36-46°F). (Minimum: 0.2 mL)
Rejection Criteria
- Specimens collected in SST tubes.
- Specimens not collected and processed as indicated.
In-Lab Processing
Centrifuge to separate serum or plasma from cells. Transfer serum or plasma to a plastic transport tube and refrigerate (2-8°C or 36-46°F). Maintain urine specimen refrigerated.
Transport: 1.0 mL serum, plasma, or urine, refrigerated (2-8°C or 36-46°F). (Minimum: 0.2 mL)
Storage
Specimen Stability for Testing:
Room Temperature (20-26°C or 68-78.8°F): 14 days
Refrigerated (2-8°C or 36-46°F): 14 days
Frozen (-20°C/-4°F or below): 8 months
Specimen Storage in Department Prior to Disposal:
Specimen retention time is determined by the policy of the reference laboratory. Contact the Send Outs Laboratory with any questions.
Laboratory
Sent to ARUP Laboratories, Salt Lake City, UT, forwarded to National Medical Services (NMS), Willow Grove, PA.
Performed
Thursday.
Results available in 3-10 days.
Reference Range
By report.
Test Methodology
High Performance Liquid Chromatography (HPLC) / Tandem Mass Spectrometry (LC-MS/MS).
Interpretation
Nefazodone (Serzone) was recently approved for the treatment of depression. Nefazodone appears to have fewer incidences of nervousness, anxiety, tremor and possible sexual dysfunctions than many other antidepressant drugs.
Nefazodone is rapidly and completely absorbed following oral administration with extensive first pass metabolism. Peak levels are typically reached at approximately 1.2 hours with a half-life of 2-4 hours. The pharmacokinetics are non-linear with markedly increased plasma levels seen with increases in dose and over time. Steady state plasma levels are attained within 4-5 days (2).
Clinical Utility
This assay is used for the therapeutic monitoring and toxicity assessment of nefazodone.
Reference
- Ferry N., et. al., Influence of Hepatic Impairment on the Pharmacokinetics of Nefazodone and Two of its Metabolites After Single and Multiple Oral Doses, Fundam. Clin.Pharmacol., 8 (1994) 463-473.
- Olin B.R. (editor-in-chief), Drug Facts and Comparisons Monthly Update, Facts and Comparisons, Inc., St. Louis, MO, March 1995, pp. 263Y-264C.
CPT Codes
80338
Contacts
Send Outs Laboratory – RO
248-551-9045
Name: Send Outs Laboratory – RO
Location:
Phone: 248-551-9045
Last Updated
10/10/2023
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.